Try our beta test site
4447 studies found for:    Japan
Show Display Options
Rank Status Study
1 Not yet recruiting Study to Evaluate the Safety and Tolerability of a Once Daily Dose of 50 mg E2609 in Healthy Japanese Subjects
Condition: Healthy Participants
Interventions: Drug: E2609;   Drug: Placebo
2 Not yet recruiting First-in-Human Dose Escalation Study of M201-A in Healthy Japanese Subjects
Condition: Healthy Volunteers
Interventions: Drug: M201-A Injection;   Drug: Placebo
3 Recruiting Cognitive Rehabilitation During Transcranial Direct Current Stimulation
Conditions: Transcranial Direct Current Stimulation;   Neurocognitive Disorders
Intervention: Device: transcranial direct current stimulation
4 Recruiting TRK-700 Drug-Drug Interaction Study With Digoxin and Midazolam
Condition: Healthy
Interventions: Drug: TRK-700;   Drug: Digoxin;   Drug: Midazolam
5 Recruiting A Phase 1, Bio-equivalence Study of TAK-536 Pediatric Formulation
Condition: Japanese Healthy Adult Male Participants
Intervention: Drug: TAK-536 10mg
6 Recruiting Study of DS-1001b in Patients With Gene IDH1-Mutated Gliomas
Condition: Glioma
Intervention: Drug: DS-1001b
7 Not yet recruiting Acceptance and Commitment Therapy With Vestibular Rehabilitation for Chronic Dizziness
Condition: Chronic Dizziness
Interventions: Behavioral: ACT with VR;   Behavioral: self-treatment VR;   Other: clinical management
8 Recruiting L-carnitine Corrects Ammonia Metabolism in Hepatectomized Patients
Condition: Ammonia Metabolism
Interventions: Drug: L-carnitine;   Other: usual intake
9 Completed Comparisons of Morphological Measurement Between Coronary Computed Tomography and Optical Coherence Tomography
Condition: Coronary Artery Disease
Intervention: Other: data collection, non-intervention
10 Recruiting Japanese Post-Market Cohort Study
Conditions: Smoking;   Tobacco Product
11 Recruiting MR Images Variation With or Without Denture Wear
Condition: Magnetic Resonance Imaging
Intervention: Device: denture wear.
12 Recruiting A Single Intravenous Dose Study of E3112 in Japanese Healthy Adult Male Subjects
Condition: Healthy Male Volunteers
Interventions: Drug: Placebo;   Drug: E3112
13 Completed Prevenar13 Drug Use Investigation - Adults Aged 65 Years or Older-
Condition: Adult Not Younger Than 65 Years
14 Recruiting Dose-escalation Trial of the Safety, Pharmacokinetics, and Pharmacodynamics of Iron Isomaltoside (Monofer®)
Conditions: Anemia;   Deficiency Diseases;   Anemia, Iron Deficiency;   Hematologic Disease;   Iron Metabolism Disorders
Intervention: Drug: Iron Isomaltoside
15 Recruiting Effect and Safety of Local Injection of Botulinum Toxin Type B Against Digital Ulcer in Systemic Sclerosis
Condition: Systemic Sclerosis Patients With Digital Ulcers
Interventions: Drug: Botulinum toxin type B (2500 units / vial);   Drug: Physiological saline
16 Not yet recruiting Trial of Lenvatinib Plus Pembrolizumab in Subjects With Selected Solid Tumors
Condition: Solid Tumors
Interventions: Drug: lenvatinib;   Drug: pembrolizumab
17 Recruiting Study of FYU-981 in Hyperuricemia With or Without Gout
Condition: Hyperuricemia With or Without Gout
Intervention: Drug: FYU-981
18 Recruiting A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Following Subcutaneous Injection of JNJ-64304500 in Healthy Japanese and Caucasian Male Participants
Condition: Healthy
Interventions: Drug: JNJ-64304500;   Drug: Placebo
19 Recruiting A Phase 1/2 Study of Ramucirumab Plus Nivolumab in Participants With Gastric or GEJ Cancer
Conditions: Gastric Cancer;   Gastroesophageal Junction Region (GEJ) Cancer
Interventions: Biological: Ramucirumab;   Biological: Nivolumab
20 Recruiting Efficacy of Olmesartan on Cerebral Glucose Metabolism, Vascular Inflammation and Adipose Tissue
Condition: Efficacy of Olmesartan on Cerebral Glucose Metabolism in Essential Hypertension
Interventions: Drug: Olmesartan;   Drug: Amlodipine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.